tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

NVAX Stock Latest News

Novavax asked for new Covid-19 vaccine trial by FDA, WSJ reports
The FlyNovavax asked for new Covid-19 vaccine trial by FDA, WSJ reports
15h ago
NVAX
Novavax asked by FDA to complete additional COVID trial, WSJ says
PremiumThe Fly
Novavax asked by FDA to complete additional COVID trial, WSJ says
16h ago
NVAX
Novavax down 10% after WSJ report on FDA request for additional vaccine trial
PremiumThe Fly
Novavax down 10% after WSJ report on FDA request for additional vaccine trial
16h ago
NVAX
Novavax has improved clarity on path forward for Nuvaxovid, says BofA
PremiumThe Fly
Novavax has improved clarity on path forward for Nuvaxovid, says BofA
3d ago
NVAX
Unusually active option classes on open April 23rd
PremiumThe Fly
Unusually active option classes on open April 23rd
3d ago
DD
IBB
Novavax’s Biologics License Application Nears Approval
PremiumCompany AnnouncementsNovavax’s Biologics License Application Nears Approval
3d ago
8K
NVAX
Novavax says received formal PMC request from FDA related to COVID vaccine
Premium
The Fly
Novavax says received formal PMC request from FDA related to COVID vaccine
3d ago
NVAX
Promising Results from Novavax’s SHIELD-Utah Study Boost Buy Rating Amid Vaccine Market Dynamics
Premium
Ratings
Promising Results from Novavax’s SHIELD-Utah Study Boost Buy Rating Amid Vaccine Market Dynamics
10d ago
NVAX
Novavax’s COVID-19 vaccine shows lower side effects vs. Pfizer-BioNTech’s
PremiumThe Fly
Novavax’s COVID-19 vaccine shows lower side effects vs. Pfizer-BioNTech’s
11d ago
PFE
BNTX
Novavax’s Strategic Positioning and Strong Efficacy Drive Buy Rating
PremiumRatings
Novavax’s Strategic Positioning and Strong Efficacy Drive Buy Rating
15d ago
NVAX
Novavax Faces Uncertainty Amid BLA Approval Delays and Regulatory Challenges
PremiumRatings
Novavax Faces Uncertainty Amid BLA Approval Delays and Regulatory Challenges
15d ago
NVAX
Novavax says ‘no official response’ from FDA on BLA status for COVID shot
PremiumThe Fly
Novavax says ‘no official response’ from FDA on BLA status for COVID shot
16d ago
NVAX
Novavax price target lowered to $10 from $12 at BofA
PremiumThe FlyNovavax price target lowered to $10 from $12 at BofA
16d ago
SNY
NVAX
Novavax slides after RFK Jr. casts doubts about COVID vaccine
Premium
The Fly
Novavax slides after RFK Jr. casts doubts about COVID vaccine
16d ago
PFE
MRNA
Novavax call volume above normal and directionally bullish
Premium
The Fly
Novavax call volume above normal and directionally bullish
22d ago
NVAX
Novavax’s Regulatory Uncertainty and Market Potential: Hold Rating Maintained
PremiumRatings
Novavax’s Regulatory Uncertainty and Market Potential: Hold Rating Maintained
22d ago
NVAX
Novavax believes BLA ‘ready for approval,’ waiting on action from FDA
PremiumThe Fly
Novavax believes BLA ‘ready for approval,’ waiting on action from FDA
24d ago
NVAX
Novavax put volume heavy and directionally bearish
PremiumThe Fly
Novavax put volume heavy and directionally bearish
24d ago
NVAX
Novavax Covid vaccine unlikely to be approved soon, WSJ says
PremiumThe Fly
Novavax Covid vaccine unlikely to be approved soon, WSJ says
24d ago
NVAX
Novavax falls 4% to $5.76 after WSJ report on unlikely approval
PremiumThe FlyNovavax falls 4% to $5.76 after WSJ report on unlikely approval
24d ago
NVAX
Marks’ Resignation Is a ‘Blow for Biotech Industry,’ Says RBC Analyst as Biotech Stocks Fall
Premium
Market News
Marks’ Resignation Is a ‘Blow for Biotech Industry,’ Says RBC Analyst as Biotech Stocks Fall
25d ago
GILD
LEGN
Unusually active option classes on open March 31st
Premium
The Fly
Unusually active option classes on open March 31st
26d ago
PG
UA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >